New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

New Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central ...

Leon Wang, EVP international and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese ...

The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton ...

Evogene Ltd. , a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The group’s five-point plan provides a window into how drugmakers hoped to influence Trump — who initially backed Medicare negotiations on the campaign trail in 2016 — during the early days of his ...

AstraZeneca blames its high prices, in part, on pharmacy benefit managers, which work as middlemen between drug companies and insurers. The company would not specifically commit to maintaining the ...

Zenas BioPharma, Inc. ("Zenas" or the "Company") , a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...

Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

This article highlights several inspiring men and women working across academia and industry who are breaking barriers and ...

In the context of the pharma sector, it’s safe to say that India is no longer just the pharmacy of the world ... from ...